Form 8-K - Current report:
SEC Accession No. 0001104659-26-094542
Filing Date
2026-08-12
Accepted
2026-08-12 08:35:13
Documents
41
Period of Report
2026-08-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K apre-20260812x8k.htm   iXBRL 8-K 41188
2 EX-99.1 apre-20260812xex99d1.htm EX-99.1 156741
3 EX-99.2 apre-20260812xex99d2.htm EX-99.2 49289
4 GRAPHIC apre-20260812xex99d1001.jpg GRAPHIC 5545
5 GRAPHIC apre-20260812xex99d2g001.jpg GRAPHIC 156315
6 GRAPHIC apre-20260812xex99d2g002.jpg GRAPHIC 321149
7 GRAPHIC apre-20260812xex99d2g003.jpg GRAPHIC 191539
8 GRAPHIC apre-20260812xex99d2g004.jpg GRAPHIC 162432
9 GRAPHIC apre-20260812xex99d2g005.jpg GRAPHIC 168697
10 GRAPHIC apre-20260812xex99d2g006.jpg GRAPHIC 86151
11 GRAPHIC apre-20260812xex99d2g007.jpg GRAPHIC 225595
12 GRAPHIC apre-20260812xex99d2g008.jpg GRAPHIC 174240
13 GRAPHIC apre-20260812xex99d2g009.jpg GRAPHIC 138891
14 GRAPHIC apre-20260812xex99d2g010.jpg GRAPHIC 148821
15 GRAPHIC apre-20260812xex99d2g011.jpg GRAPHIC 140312
16 GRAPHIC apre-20260812xex99d2g012.jpg GRAPHIC 148402
17 GRAPHIC apre-20260812xex99d2g013.jpg GRAPHIC 112781
18 GRAPHIC apre-20260812xex99d2g014.jpg GRAPHIC 179771
19 GRAPHIC apre-20260812xex99d2g015.jpg GRAPHIC 80464
20 GRAPHIC apre-20260812xex99d2g016.jpg GRAPHIC 97951
21 GRAPHIC apre-20260812xex99d2g017.jpg GRAPHIC 173282
22 GRAPHIC apre-20260812xex99d2g018.jpg GRAPHIC 151156
23 GRAPHIC apre-20260812xex99d2g019.jpg GRAPHIC 213876
24 GRAPHIC apre-20260812xex99d2g020.jpg GRAPHIC 169432
25 GRAPHIC apre-20260812xex99d2g021.jpg GRAPHIC 159274
26 GRAPHIC apre-20260812xex99d2g022.jpg GRAPHIC 95739
27 GRAPHIC apre-20260812xex99d2g023.jpg GRAPHIC 199627
28 GRAPHIC apre-20260812xex99d2g024.jpg GRAPHIC 101971
29 GRAPHIC apre-20260812xex99d2g025.jpg GRAPHIC 166224
30 GRAPHIC apre-20260812xex99d2g026.jpg GRAPHIC 141702
  Complete submission text file 0001104659-26-094542.txt   6045569

Data Files

Seq Description Document Type Size
31 EX-101.SCH apre-20260812.xsd EX-101.SCH 3494
32 EX-101.DEF apre-20260812_def.xml EX-101.DEF 2844
33 EX-101.LAB apre-20260812_lab.xml EX-101.LAB 16593
34 EX-101.PRE apre-20260812_pre.xml EX-101.PRE 10903
44 EXTRACTED XBRL INSTANCE DOCUMENT apre-20260812x8k_htm.xml XML 4677
Mailing Address 3805 OLD EASTON ROAD DOYLESTOWN PA 18902
Business Address 3805 OLD EASTON ROAD DOYLESTOWN PA 18902 215-948-4119
Aprea Therapeutics, Inc. (Filer) CIK: 0001781983 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39069 | Film No.: 261265447
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)